www.shtfplan.com ·
Federal COVID Vaccine Injury Program Compensates Another Death Denial Rate Remains Above 98
Executive Summary
AI-generatedThe federal Countermeasures Injury Compensation Program (CICP) has approved a payout for one death attributed to a COVID-19 vaccine, marking its fifth such approval. However, the program's overall denial rate for these injury claims remains extremely high, consistently above 98%. Critics argue that the legal standards and immunity provisions make it nearly impossible for claimants to receive compensation.
The article discusses the operational and legal status of a government compensation program (CICP) related to medical adverse events following vaccination. This is a public health/legal matter and does not describe any direct commercial mechanism affecting product pricing, supply chain costs, or corporate margins.
Key Insights
- The CICP, established under the PREP Act, provides compensation for injuries from declared countermeasures like COVID-19 vaccines.
- Despite a recent death payout, the program has denied over 98% of all submitted claims for vaccine injury.
- Claimants must prove causation by a preponderance of evidence, a standard critics argue is too difficult to meet.
- The PREP Act grants broad immunity to manufacturers and prevents lawsuits seeking money damages in court.
- Advocates point out that the U.S. compensation rate is significantly lower compared to other countries, such as South Korea.
Topic context
The full article is on the original publisher site.